• 1
    Gelson W, Hoare M, Unitt E, Palmer C, Gibbs P, Coleman N, et al. Heterogeneous inflammatory changes in liver graft recipients with normal biochemistry. Transplantation 2010; 89: 739748.
  • 2
    Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl 2012; 18: 11541170.
  • 3
    Adeyi O, Fischer SE, Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation. J Clin Pathol 2010; 63: 4774.
  • 4
    Andreu H, Rimola A, Bruguera M, Navasa M, Cirera I, Grande L, et al. Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy. Transplantation 2002; 73: 19361943.
  • 5
    Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci 2012; 57: 22482266.
  • 6
    Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, et al. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology 2012; 142: 11321139.
  • 7
    Selzner N, Guindi M, Renner EL, Berenguer M. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. J Hepatol 2011; 55: 207217.
  • 8
    Syn WK, Nightingale P, Gunson B, Hubscher SG, Neuberger JM. Natural history of unexplained chronic hepatitis after liver transplantation. Liver Transpl 2007; 13: 984989.
  • 9
    Walter T, Dumortier J, Guillaud O, Hervieu V, Paliard P, Scoazec JY, et al. Rejection under alpha interferon therapy in liver transplant recipients. Am J Transplant 2007; 7: 177184.
  • 10
    Adeyi O. Liver transplant pathology. In: Ferrell LD, Kakar S, eds. Consultant Pathology: Liver Pathology. 1st ed. New York, NY: Demos Medical; 2011: 307342.
  • 11
    Selzner N, Renner EL, Selzner M, Adeyi O, Kashfi A, Therapondos G, et al. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. Transplantation 2009; 88: 12141221.
  • 12
    Fiel MI, Schiano TD. Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant 2012; 17: 287292.
  • 13
    Hubscher SG. What is the long-term outcome of the liver allograft? J Hepatol 2011; 55: 702717.